Gene expression signature for recurrence in stage III colorectal cancers

Cancer

Volumn 115, Issue 2, 2009, Pages 283-292

  Watanabe, Toshiaki ^a   Kobunai, Takashi ^a   Sakamoto, Etsuko ^b   Yamamoto, Yoko ^a   Konishi, Tsuyoshi ^c   Horiuchi, Atsushi ^a   Shimada, Ryu ^a   Oka, Toshinori ^b   Nagawa, Hirokazu ^c  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

CABIN1; Colorectal cancer; Copy number; Duke stage C; Lymph node metastasis; Microarray; Prediction; Recurrence; Stage III; Tailored therapy

Indexed keywords

BINDING PROTEIN; CALCINEURIN; CALCINEURIN BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOSS; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SAMPLING;

CALCINEURIN; COLORECTAL NEOPLASMS; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION;

EID: 59449083459     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24023     Document Type: Article

References (20)

1. Watanabe T, Wu TT, Catalano PJ, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med. 2001;344:1196-1206.
2. Clarke PA, te Poele R, Wooster R, Workman P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Bio-chem Pharmacol. 2001;62:1311-1336.
3. Chin KV, Kong AN. Application of DNA microarrays in pharmacogenomics and toxicogenomics. Pharm Res. 2002;19:1773-1778.
4. Watanabe T, Komuro Y, Kiyomatsu T, et al. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene-expression profiles. Cancer Res. 2006;66:3370-3374.
5. atanabe T, Kobunai T, Toda E, et al. Gene expression ignature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray. Clin Cancer Res. 2007;13:415-420.
6. Watanabe T, Kobunai T, Toda E, et al. Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. Cancer Res. 2006;66:9804-9808.
7. Buckley PG, Mantripragada KK, Diaz de Stahl T, et al. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibro-matosis type 2. Hum Mutat. 2005;26:540-549.
8. Cover TM, Hart PE. Nearest neighbor pattern classification. IEEE Trans Inf Theory. 1967;13:21-27.
9. Wang TL, Maierhofer C, Speicher MR, et al. Digital kar-yotyping. Proc Natl Acad Sci USA. 2002;99:16156-16161.
10. Zhao X, Li C, Paez JG, et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 2004;64:3060-3071.
11. Arango D, Laiho P, Kokko A, et al. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology. 2005;129:874-884.
12. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology. 1993;104:57-64.
13. Benhattar J, Losi L, Chaubert P, et al. Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology. 1993;104:1044-1048.
14. Goh HS, Yao J, Smith DR. p53 point mutation and survival in colorectal cancer patients. Cancer Res. 1995;55: 5217-5221.
15. Pauletti G, Godolphin W, Press MF, Slamon DJ. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. 1996;13:63-72.
16. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet. 2005;37(suppl):S11-S17.
17. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res. 2000;463: 247-283.
18. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300:271-276.
19. Zhang H, Ahmadi A, Arbman G, et al. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int JCancer. 1999;84:135-138.
20. Youn HD, Liu JO. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity. 2000;13:85-94.